Literature DB >> 1092638

The gentamicin antibiotics. 6. Gentamicin C2b, an aminoglycoside antibiotic produced by Micromonospora purpurea mutant JI-33.

P J Daniels, C Luce, T L Nagabhushan.   

Abstract

A mutant strain of Micromonospora purpurea, designated var. JI-33, produced an antibiotic complex consisting primarily of gentamicin C1a. A further product of this fermentation was identical to a very minor component isolated from the fermentation of the parent organism and named gentamicin C2b. Physical measurements indicated its structure to be 6'-N-methylgentamicin C1a and this was confirmed by synthesis from gentamicin C1a. The in vitro antibacterial activity of gentamicin C2b was very similar to that of the gentamicin C complex. Antibiotic XK-62-2, produced by Micromonospora sagamiensis, appears to be identical to gentamicin C1b.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1092638     DOI: 10.7164/antibiotics.28.35

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  5 in total

1.  Biotransformation of sisomicin to gentamicin C2b.

Authors:  B K Lee; J V Bailey; R G Condon; J A Marquez; G H Wagman; M J Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

Review 2.  Aminoglycoside research 1975-1985: prospects for development of improved agents.

Authors:  K E Price
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

3.  Antibiotic biosynthesis by cofermentation of blocked mutants of two Micromonospora species.

Authors:  B K Lee; T L Nagabhushan; R G Condon; A B Cooper; J A Waitz
Journal:  Antimicrob Agents Chemother       Date:  1978-07       Impact factor: 5.191

4.  Biosynthetic pathway leading to gentamicin C2b.

Authors:  B K Lee; T L Nagabhushan; R G Condon; G Shimonaski; M G Kalyanpur; M Patel; J A Waitz
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

5.  Synergy Pattern of Short Cationic Antimicrobial Peptides Against Multidrug-Resistant Pseudomonas aeruginosa.

Authors:  Serge Ruden; Annika Rieder; Irina Chis Ster; Thomas Schwartz; Ralf Mikut; Kai Hilpert
Journal:  Front Microbiol       Date:  2019-11-28       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.